Risks versus benefits of long-term proton pump inhibitor therapy in the elderly.
Schuler
Amy
A
University of Maryland School of Nursing, MD, USA.
D000368:Aged; D000897:Anti-Ulcer Agents / Q000009:adverse effects*; D016360:Clostridioides difficile; D003015:Clostridium Infections / Q000139:chemically induced; D004334:Drug Administration Schedule; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced; D010437:Peptic Ulcer / Q000188:drug therapy*; D010818:Practice Patterns, Physicians'; D054328:Proton Pump Inhibitors; D012141:Respiratory Tract Infections / Q000139:chemically induced; D012307:Risk Factors; D017751:Safety Management; D013997:Time Factors
D000897:Anti-Ulcer Agents; D054328:Proton Pump Inhibitors